American Diabetes Association 86th Scientific Sessions 2026

Description

+ Include:  videos + file sub vtt +  pdf, size:  GB

+ Target Audience: Endocrinologists, Cardiologists, Nephrologists, Primary Care Physicians

+ Sample video: contact me for sample video

+ Information:

The 2026 American Diabetes Association’s (ADA’s) Scientific Sessions is the largest and most prominent conference in the world focused on diabetes, bringing together research, clinical care, and innovation. The scientific program features over 200 sessions designed to expand professional knowledge and highlight the latest breakthroughs in diabetes care, including symposia, late-breaking clinical trials, and panel discussions. It distills the latest care standards from the ADA’s Standards of Care in Diabetes and convenes the professional community to share ideas and network.

Learning Objectives

• Evaluate new pharmacological advancements and adjunct therapies, such as GLP-1 receptor agonists and dual agonists, for managing Type 1 and Type 2 diabetes.

• Understand the integration of continuous glucose monitoring (CGM), artificial intelligence (AI), and automated insulin delivery systems into clinical health care delivery.

• Apply a holistic approach to diabetes care that addresses the intersection of heart, kidney, and metabolic health.

• Identify and implement novel strategies for hypoglycemia prevention, weight management, and tackling diabetes-related complications.

• Translate updated nutritional guidelines, behavioral interventions, and ADA Standards of Care into practical patient management strategies across diverse populations.

Target Audience

• Annually welcoming over 12,000 researchers and clinicians, including physicians, nurses, endocrinologists, cardiologists, registered dietitian nutritionists, and others, this conference distills the latest care standards from the ADA’s Standards of Care in Diabetes, brings the newest research to the forefront, and convenes the diabetes professional community to share ideas, network, and form connections.
• Best for Endocrinologists, Cardiologists, Nephrologists, Primary Care Physicians, and Registered Dietitian Nutritionists.

Topics

• GLP-1 Receptor Agonists: What’s New in 2026?

• REIMAGINE 1, 2, 3: Leveraging Amylin and GLP-1 for Type 2 Diabetes Care with CagriSema

• Dual Agonism in Type 1 Diabetes: Unveiling Efficacy and Safety of Adjunct Therapy with CT-868 (GLP-1/GIP RA) in Adults with Type 1 Diabetes—Phase 1 and 2 Results

• From Pen to Pill: Achieving a Paradigm Shift in Type 2 Diabetes—The Orforglipron “ACHIEVE” Clinical Trial Program

• AI and Innovation for Clinical Health Care Delivery in DM

• Where Heart, Kidney, and Metabolism Collide: Innovations in the Holistic Approach to Care

• The New Frontier of Hypoglycemia Prevention: Pathophysiology, Therapies, Technology, and Care

• From Patients to Partners Elevating Voices in Diabetes and Obesity Care President Health Care Education Address and Distinguished Internatio

• Illuminating Dexcom Innovations Across the Metabolic Continuum Stelo Supporting Health Behavior Change and Dexcom G7 15 Day with Smart Basal

• MiniMed Introducing New Insulin Delivery Systems

• National Scientific Health Care Achievement Awards Presentation Outstanding Scientific Achievement Award Lecture and Outstanding Educator in

• 2026 ADA State of Type 1 Diabetes

• 2026 DiabetesDiabetes CareDiabetologia Symposium Where Are the Islet Lesions Underlying Type 2 Diabetes

• ADA Diabetes Care Symposium The Oscillation of Diabetes and the Environment

• ADA Diabetes Journal Symposium Non-Classical Complications of DiabetesEpidemiology Mechanism Treatment

• ADA Diabetes Obesity and Cardiometabolic CARE DOCM CARE Journal Symposium The Cost of Obesity and its Treatment

• ADA DSMESNutrition Symposium Disordered Eating in Diabetes and Obesity

• ADA ERP Symposium Standardizing Diabetes Education on a Global Level

• ADA Statement on Diabetes Technology in Primary Care

• Adapting Diabetes Care for All With Felicia Hill-Briggs Trailblazer in Health Equity Award Lecture

• Addressing the Growing Diabetes Epidemic Global Perspectives

• Advances in Metabolic Therapeutics A Focus on Insulin Sensitivity and Adipose Function

• Advancing Diabetes Epidemiology with Real-World Data and AI

• AI Integration into diabetes technology

• Albuminuria and Cardiovascular Risk The Power of Early Screening Detection and CKD Diagnosis

• Amylin as a Novel Diabetes and Obesity Therapy

• Anticipated and Unanticipated Side Effects of SGLT2 Inhibitors in Diabetes

• Are GLP-1 Receptor Agonists Safe for the Eyes

• Are We Ready to Meet the Needs of Older Adults with Type 1 Diabetes

• AZD5004 A Novel Oral Small Molecule GLP 1 Receptor Agonist OverweightObesity VISTA and Type 2 Diabetes SOLSTICE Phase 2 Trial Results

• B Cells in Type 1 Diabetes Hidden Culprits or Passive Participants

• Beta-Cell Replacement in Pediatric Type 1 Diabetes Promise and Perspective

• Beyond A1C New Ways to Measure Disease Progression in Early-Stage Type 1 Diabetes With ADA Presidents Select Abstract Presentation

• Beyond Conventional Care Regenerative Medicine and Smart Dressings for Diabetic Foot Ulcer

• Beyond Engraftment Functional Readouts Counterregulation and the Lived Experience of Islet Transplantation

• Beyond Glucose Monitoring The Next Revolution of Diabetes Sensing Technology with Libre

• Beyond Insulin Adjunctive Therapies for Pediatric Type 1 Diabetes

• Beyond Screening Supporting Mental and Behavioral Health among Youth and Families at Risk for Stage 3 Type 1 Diabetes

• Beyond Sugar Synapses and Senescence

• Biology and Assessment of Cardiovascular Risk

• BMI on Trial Should It Still Define Obesity

• Breaking the Pain Chain Practical Strategies for Diabetic Neuropathy from Diagnosis to Treatment

• Bridging the Gap Advancing Stem CellDerived Beta-Cell Therapy toward Widespread Clinical Use

• Bridging the Gap Real-Time Diabetes Technology Organizational Readiness and Policy Solutions to Advance Care

• Building a Multidisciplinary Model for Behavior Change in Cardiometabolic Health

• Central Command or Can We Insights into whether Modulating the Nervous System Can Improve Metabolic Health

• Clinical Algorithm for the Identification Monitoring and Management of Elevated Ketones in Ambulatory Settings

• Consensus or Controversy Hot Topics in Nutrition 2026

• Contemporary and Emerging Diabetes Technologies and Therapies Psychosocial and Behavioral Considerations With Richard R Rubin Award Lecture

• Continuous Ketone Monitoring for the Masses Risky or Rewarding

• Control-IQ in Pregnancy Results from the CIRCUIT Randomized Controlled Trial

• Controlling the Metabolic Phenotype of Fat New Insights into Local and Distal Signals

• Counterregulatory Responses to Hypoglycemia New Tools and Therapeutic Levers

• Decoding Islet Electrophysiology Channels Pumps and Metabolic Coupling

• Determinants of B-Cell Immunogenicity and Survival in Type 1 Diabetes

• Diabetes Care and Education for Everyone Wherever They Are

• Diabetes on the Radar From Smart Data to Smarter Policy

• Diabetes Prediction with Polygenic and Metabolic Risk Scores

• Diabetes Technology Use Across Life Situations

• Diabetes Year in Review Major Advances and Discoveries

• Discussion on Behavioral Medicine and Psychology Beyond BoundariesExpanding Your Behavioral Medicine Research Portfolio

• Discussion on Clinical Centers and Programs Diabetes Management in Older AdultsChallenges and Opportunities

• Discussion on Diabetes and Cardiovascular Disease Implementing a Multi-Disciplinary Approach in Patients with Diabetes and Cardiovascular Di

• Discussion on Diabetes in Primary Care Optimizing Use Safety and Tolerability of Diabetes Medications

• Discussion on Diabetes in Youth From Uncertainty to ActionMobilizing Advocacy for Type 1 and Type 2 Diabetes Amid Shifting Landscapes

• Discussion on Diabetes Self Management Education and Support DSMES Advancing Prandial Insulin Education Within DSMESFindings from a Toolkit

• Discussion on Diabetes Technology Addressing Unmet Needs in Diabetes TechnologyExpanding Access to Devices

• Discussion on Exercise Physiology MoTrPACWhat Does It Tell Us About Diabetes and Physical Activity

• Discussion on Eye Health Use of AI in Diabetic Retinopathy Screening

• Discussion on Foot Care Revolutionizing Diabetic Limb SalvageVascular Innovation Bone Health and Regenerative Strategies in Lower Extremitie

• Discussion on Health Care Delivery and Quality Improvement From Best Practices to ValueScaling Diabetes Expertise Through Innovation

• Discussion on Immunology and Beta-Cell Replacement Immune Tolerance in Type 1 DiabetesHarnessing the Power of Regulatory T Cells

• Discussion on Islet Biology Development and Function Small but MightyExtra Islet Beta Cells are Preserved or Lost in Type 1 Diabetes

• Discussion on Nutritional Science and Metabolism Diabetes and Nutrition Across the Perinatal ContinuumFrom Preconception to Postpartum

• Discussion on Obesity Reclaiming the Full Spectrum of Obesity Care

• Discussion on Pregnancy and Reproductive Health Adverse Outcomes in GDM-Hyperglycemia or Obesity

• Discussion on Public Health and Epidemiology Leveraging Technology to Disseminate Diabetes Care to Under-Resourced Populations

• Discussion on Womens Interprofessional Network of the ADA WIN ADA The Adaptive EdgeHow to Lead Through Change Panel Discussion

• Diverse Nutritional Approaches to Modify Metabolism in Type 2 Diabetes

• Early Pregnancy Diabetes Screening Reexamined GO MOMs or Hold Tight

• Emerging Insights from Type 1 Diabetes Immunotherapy Clinical Trials

• Empowering Populations Diabetes Self Management Education in Practice

• Engaging Science Talks that Matter

• Everyone Should Screen for PAD

• Exercise in the Age of Digital Health

• Exercise Signals and the Interorgan Metabolic Dialogue

• Evolving Therapies for MASH

• Exercise Breaks

• Exercise Training Fatigue and Motivation

• Expanding Health Access Translating Science into Practice Through Community-Engaged Approaches

• Expanding the Beta-Cell Pool Whats New with Proliferation Neogenesis and Transdifferentiation

• Explore Advancements in Type 1 Diabetes Management

• Food Is Medicine Outcomes for Diabetes Management Comparative Effectiveness across Populations

• From Evidence to the Plate What the New Nutrition Guidelines Mean for Diabetes Care

• From Innovation to Integration Redefining the Scale and Sustainability of Diabetes Prevention Through a National Framework

• From Plate to Pancreas Mechanisms Linking Diet to Diabetes With ADA Presidents Select Abstract Presentation

• From Symptoms to Solutions The Patient Experience with Korlym mifepristone Treatment

• Frontiers in Diabetic Nerve Health Biomarkers Risk Diagnosis and Treatment

• Getting Along with Your Algorithm

• Global Advances in Research to Address Heterogeneity of Diabetes NIDDK

• Global Perspectives on Obesity Care

• GLP-1 and What Else Preclinical Obesity Studies

• GLP-1 Receptor Agonists The Optimal First-Line Therapy for Early Pediatric Type 2 Diabetes

• GLP-1RA Across the Lifespan Who When and at What Cost

• Glucagon Pharmacology as a Metabolic SignalA Lightning Talk Series

• Glucagon Takes the Stage Regulation Secretion and When the Pancreas Goes Off-Script

• Goals in Common Recent Updates to the GuidelinesBlood Pressure Lipids and Heart Failure

• Harnessing Big Data to Decode Immune Mechanisms in Type 1 Diabetes

• Harnessing Technology to Tackle Diabetes Distress Innovations across Diabetes Types and Life Stages

• Hepatic Signaling Networks Driving Metabolic Dysfunction and MASLD

• Hope or Hype Microbiome as New Frontier for Type 2 Diabetes and Obesity

• How Do Lipoproteins Control Blood Glucose LevelsInsulin Secretion Insulin Sensitivity

• How Do We Close Gaps in Access to Obesity Care

• How Does MASLD Impact Lipoprotein Biology and Cardiovascular Risk with Obesity and Diabetes

• How to Best Combine Therapies for Patients with Diabetic Kidney Disease

• Human Islet Cell Identity and Organization

• Human Studies in Obesity Treatment Emerging Therapeutic Options and Strategies for Decision-Making

• Hypercortisolism The Evidence The Evolution The Implications

• Hypoglycemia across Contexts Risk Recognition and Real-World Safety With ADA Presidents Select Abstract Presentation

• Hypothalamic Circuits and Neuroendocrine Control of Glucose Homeostasis

• Identification and Stratification of Patients at High CV Risk without a Prior MI or Stroke Insights from Real-World Evidence and the VESALIU

• Immediate AI Integration into Health Care Delivery Considering Costs Quality and Clinician Burnout

• Immune Heterogeneity and Endotypes in Type 1 Diabetes Insights from Human Studies and Humanized Models

• Immune Modulatory Strategies for Next-Generation Cell Therapies

• Immune System Engineering for Type 1 Diabetes From Mechanisms to Therapies

• In Search of Novel Therapeutic Targets in Diabetic Retinopathy

• Innovative Approaches to Weight Management

• Inpatient Glucose Management Clinical and Quality Perspectives in the Age of eCQMs

• Insulin Resistance A Cause or Consequence of Metabolic Dysfunction

• Interorgan and Intercellular Cross Talk in Steatotic Liver

• Is Obesity Accelerated Aging A Physiologic Perspective

• Its Not Up for Debate Paracrine Signaling Is Critical in Shaping Insulin Secretion

• Joint ADAAACC Symposium Expecting the BestLaboratory Issues in the Diagnosis and Management of Diabetes in Pregnancy

• Joint ADAInternational Diabetes Federation IDF Symposium What Is Malnutrition-Related Diabetes

• Joint ADAIPITA Symposium Engineering Transplantation Sites to Improve Beta-Cell Survival and Function

• Joint ADAISPAD Symposium A Global Perspective on Pediatric Type 1 Diabetes Screening

• Kelly West Award for Outstanding Achievement in Epidemiology Lecture

• Lady Parts of Life with Diabetes Behavioral and Psychosocial Care for Women

• Lancet Journal Symposium Cardiometabolic Multiple Long-Term Conditions MultimorbidityEpidemiology Mechanisms Models and Management

• Lessons from Islet Biology for Next-Generation Therapies

• Level 1 Hypoglycemia Does It Really Matter

• Make New Friends but Keep the Old Updates on Insulin Therapy in Pregnancy

• Management of Diabetic RetinopathyClinical Perspective

• Managing Diabetes across the Cancer Continuum From Treatment to Survivorship

• Mapping Diabetes Epidemiology in a Changing US Demographic Landscape

• Maternal Metabolic Health In and Beyond Pregnancy

• Maternal Metabolic Imprinting New Insights on Developmental Origins of Diabetes and Obesity

• Mechanisms and Treatments for Autonomic Dysfunction Current Evidence and Emerging Directions

• Metabolic and Glycemic Profiles in Pregnancies Affected by Diabetes

• Metabolic Control in Obesity and Diabetes via Interoception

• Metabolic Programming during Development and Aging

• Mitochondrial Energetics in Obesity

• Molecular and Therapeutic Strategies for Diabetes

• Molecular Architecture of Diabetic Retinopathy Genes and Epigenomics

• Molecular Transducers of Insulin Action and Insulin Resistance

• Multiomic Approaches and Resources for Providing Insights into Diabetes Pathophysiology

• Muscle Loss in GLP-1 Receptor AgonistInduced Weight Loss A Real Concern or Much Ado about Nothing

• Neonatal and Childhood Outcomes of Dysglycemia in Pregnancy With Norbert Freinkel Award Lecture

• Neuronal Circuits and Plasticity Linking Energy Balance and Feeding in Obesity

• New Directions and Novel ApproachesEarly Stage and PilotFeasibility Research on Innovations in Diabetes Behavioral Interventions

• New Tools Same Focus Targeting Microvascular Disease in Type 2 Diabetes

• New Ways to Learn Support and Grow in Diabetes Care With ADA Presidents Select Abstract Presentation

• Newer Concepts in Management of Diabetes and Hypertriglyceridemia

• Next-Generation Diabetic Foot Ulcer Care AI Cell Reprogramming and 3D Bioprinting With Roger Pecoraro Award Lecture

• Not All Obesity Is the Same Identifying Rare Neuroendocrine Causes

• Novel and Established Interventions to Improve Cardiovascular Outcomes

• Novel Approaches to Glucose Control With ADA Presidents Select Abstract Presentation

• Novel Insights into Basics Mechanisms and Therapeutic Interventions in Type 1 Diabetes

• Novel Metabolic Drivers Underlying the Development of Obesity

• Obesity Year in Review Major Advances and Discoveries

• Old and New Tools to Understand Cardiovascular Risk With Edwin Bierman Award Lecture

• Old Problems Bold Solutions Transforming Diabetes Screening with Innovative Solutions

• Organellar Metabolite Carriers A New Frontier in Metabolic Research

• Overcoming Technology Limitations

• Pathways Regulating Glycemia Insulin Sensitization B-Cell Reserve and Glucose Sensing

• Personalizing Diabetes Care Tailoring the Intervention to the Cardiovascular Risk

• Perspectives from ADA Banting Medalists on Obesity Pathogenesis Current State and Future Directions

• Perturb Observe What Pharmacologic Challenges Reveal about Human Metabolism

• Pharmacogenomic Responses in Diabetes From Mice to Medications

• Physiological Effects of Exercise

• Precision Medicine in Diabetes Is It Time to Bring Genetics to the Clinic

• Pregnancy Pregame Hot Topics in Preconception Management of Diabetes and Obesity

• Preserving Lean Mass with GLP-1R Therapy Preclinical Obesity Studies

• President Medicine Science Address and Banting Medal for Scientific Achievement Award Lecture

• Preventing Diabetes-Related Complications

• Preventing Type 1 Diabetes

• Quality Improvement Initiatives at Scale What Have We Learned

• Redesigning Diabetes Care What Is the Cost

• Reprogram Replicate Replace Experimental Approaches to Durable B Cell Restoration

• Rethinking RAAS Novel Strategies to Target a Classic Pathway in Diabetic Kidney Disease

• Rising Minds AI Innovations in DiabetesNIDDK Early-Career Investigator Symposium

• Session 1 Whats New with CGM Systems

• Session 1 Whats New with Insulin Delivery Systems With ADA Presidents Select Abstract Presentation

• Session 2 Whats New with CGM Systems

• Session 2 Whats New with Insulin Delivery Systems

• Severe Hypertriglyceridemia sHTG An Underrecognized Life-Threatening Disease

• Sexual Dimorphism in Islet Responses in the Setting of Diabetes and Obesity

• Short Talks from Abstracts Clinical Updates on PCSK9 Inhibition and Triglyceride-Related CVD

• Signals In Signals Out The Human BrainBody Metabolic Circuit

• Standards of Care in Overweight and Obesity 2026 Updates

• Strengthening Community Engagement Principles in Your Research Best Practices and Lessons Learned from the National Center for Engagement in

• The ADA and Centers for Diabetes Translation Research Symposium Driving Innovation in Diabetes Translation

• The ADAs Standards of Care in Diabetes 2026 Updates

• The AIDING Trial Automated Insulin Delivery in the HospitalResults and Implications for Inpatient Diabetes Care

• The Benefits of GlucagonGLP-1 Receptor Dual Agonism Insights from the SYNCHRONIZE Phase 3 Studies of Survodutide

• The Connected Continuum Reducing Clinician Burden Across Care Settings with EHR Integrated Diabetes Data

• The Diabetic Foot Consortium An NIDDK Initiative to Transform Care of the Diabetic Foot Ulcer

• The Glucagon Agonism Paradox Friend or Foe in the Fight against Hyperglycemia

• The Molecular Nexus Inflammation ECM and Angiogenesis as Therapeutic Targets for Diabetic Foot Wounds

• The Obesity Treatment Journey Evaluating Burden Discontinuation and Outcomes

• The Omnipod Difference Patient-Centered Simplicity and Breakthrough Algorithm Performance

• The Pancreas Revealed New Ways to Measure Form and Function

• The Pancreatic Ecosystem How Exocrine Tissue Orchestrates Islet Biology

• The Team The Team The Team What Works in Health Care Team Delivery

• The Transformative Power of Continuous Glucose Monitoring

• The twiist Grand Prix Precision for Every T1D Journey

• The VESPER-1 OLE -2 and -3 Trials of Berobenatide MET-097 PF-08653944 an Ultra-Long Acting GLP-1 Receptor Agonist for Weight Management

• To Pay or Not to Pay

• Top Clinical Abstracts Kidney Complications in Diabetes With ADA Presidents Select Abstract Presentation

• Top Research Abstracts Mechanisms of Diabetic Kidney Disease

• Session 3 Whats New with CGM Systems

• Translational Studies of Mechanisms Underlying Weight Gain and Long-Term Weight Loss in Obesity

• Type 1 Diabetes Trends Complications and Survival

• Undertreated and Underdiagnosed Bridging the Epidemics of Obesity and MASLD

• Unexplored Pathways of Residual Risk in Diabetic Kidney Disease to Find Novel Cures

• Unlocking the Potential of a Liver-Directed Treatment

• Update of the ADA-EASD Consensus Report on the Management of Type 1 Diabetes in Adults

• Updated Understanding of Reward Processing in Obesity in the Era of Incretin Agonists

• Using Genetics to Elucidate Atypical Diabetes

• Vapes and Vodka What Every Diabetes Professional Should Know about Addressing Adolescent and Young Adult Substance Use

• Welcome to the 2026 ADA Scientific Sessions Keynote Address by Richard Woychik PhD Pathway to Stop Diabetes Symposium

• What Works Outcomes of Behavioral Intervention Trials in Type 1 Type 2 and Gestational Diabetes

• Why Would We Do Away with the Mouse Animal and Human Research Are Complementary